[1] Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis[J]. Int J Mol Sci, 2020, 21(20):7488. DOI: 10.3390/ijms21207488.
[2] Ogawa E, Sato Y, Minagawa A, et al. Pathogenesis of psoriasis and development of treatment[J]. J Dermatol, 2018, 45(3):264-272. DOI: 10.1111/1346-8138.14139.
[3] Medovic MV, Jakovljevic VL, Zivkovic VI, et al. Psoriasis between autoimmunity and oxidative stress: changes induced by different therapeutic approaches[J]. Oxid Med Cell Longev, 2022, 2022:2249834. DOI: 10.1155/2022/2249834.
[4] Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis[J]. Free Radic Biol Med, 2009, 47(7):891-905. DOI: 10.1016/j.freeradbiomed. 2009.06.033.
[5] Lee YJ, Bae JH, Kang SG, et al. Pro-oxidant status and Nrf2 levels in psoriasis vulgaris skin tissues and dimethyl fumarate-treated HaCaT cells[J]. Arch Pharm Res, 2017, 40(9):1105-1116. DOI: 10.1007/s12272-017-0955-5.
[6] 焦晓燕,郭在培,陈涛,等.氧化应激与银屑病[J].临床皮肤科杂志,2012,41(3):189-191. DOI:10.3969/j.issn.1000- 4963.2012.03.032.
[7] 李建恒,乔亚君,侯力峰,等.丹参脂溶性有效成分丹参酮研究进展[J].河北大学学报(自然科学版),2015,35(2):217-224.
[8] 梁杰,李响.枸杞多糖与丹参酮延缓小鼠皮肤衰老的实验研究[J].中国实用医药,2009,4(9):5-6. DOI:10.3969/j.issn.1673-7555.2009.09.003.
[9] Beek CH, van Reede EC. The nature and frequency of the histological changes found in psoriasis vulgaris[J]. Arch Dermatol Res (1975), 1977, 257(3):255-264. DOI: 10.1007/BF00741841.
[10] Di Meglio P, Villanova F, Nestle FO. Psoriasis[J]. Cold Spring Harb Perspect Med, 2014, 4(8):a015354. DOI: 10.1101/cshperspect.a015354.
[11] 赵京霞,底婷婷,王燕,等.IL-23/IL-17炎症轴在咪喹莫特诱导的小鼠银屑病样皮肤损害中的作用[J].中国病理生理杂志,2013,29(6):1086-1094. DOI:10.3969/j.issn.1000- 4718.2013.06.023.
[12] Baek JO, Byamba D, Wu WH, et al. Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress[J]. Arch Dermatol Res, 2012, 304(9):699-706. DOI: 10.1007/s00403-012-1272-y.
[13] Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease[J]. Clin Exp Immunol, 2007, 148(1):32-46. DOI: 10.1111/j.1365- 2249.2007.03356.x.
[14] 朴莉玲,张春韶,唐妮,等.寻常型银屑病患者血清IL-4、IL-8、TNF-α 水平 、T细胞亚群结构与患者预后转归的关系[J].海南医学院学报,2019,25(14):1096-1099. DOI:10.13210/j.cnki.jhmu.20190619.004.
[15] Gottlieb AB, Chamian F, Masud S, et al. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques[J]. J Immunol, 2005, 175(4):2721-2729. DOI: 10.4049/jimmunol.175.4.2721.
[16] Lynde CW, Poulin Y, Vender R, et al. Interleukin 17A: toward a new understanding of psoriasis pathogenesis[J]. J Am Acad Dermatol, 2014, 71(1):141-150. DOI: 10.1016/j.jaad.2013.12.036.
[17] Furue M, Furue K, Tsuji G, et al. Interleukin-17A and keratinocytes in psoriasis[J]. Int J Mol Sci, 2020, 21(4):1275. DOI: 10.3390/ijms21041275.
[18] Brembilla NC, Senra L, Boehncke WH. The IL-17 family of cytokines in psoriasis: IL-17A and beyond[J]. Front Immunol, 2018, 9:1682. DOI: 10.3389/fimmu.2018. 01682.
[19] Mrowietz U, Szepietowski JC, Loewe R, et al. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm® - and placebo-controlled trial (BRIDGE) [J]. Br J Dermatol, 2017, 176(3):615-623. DOI: 10.1111/bjd.14947.
[20] Tao S, Justiniano R, Zhang DD, et al. The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV[J]. Redox Biol, 2013, 1(1):532-541. DOI: 10.1016/j.redox.2013.10.004.
|